Mumbai, June 2 -- Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Rifaximin Tablets, 550 mg (USRLD: Xifaxan(R) Tablets, 550 mg).

Published by HT Digital Content Services with permission from Capital Market....